INTRODUCTION: Use of proton-pump inhibitors (PPIs) for the treatment of
gastroesophageal reflux disease (GERD) in children has increased enormously. However …

Gastroesophageal reflux (GER) is defined as the involuntary retrograde passage of gastric
contents into the esophagus with or without regurgitation or vomiting. It is a frequently …

Proton pump inhibitor (PPI) use is becoming increasingly common. Although the toxicity
profiles of PPIs are not well understood particularly in children, PPIs have been associated …

Background Gastrointestinal sensorimotor dysfunction underlies a wide range of
esophageal, gastric, and intestinal motility and functional disorders that collectively …

The aims of gastroesophageal reflux disease (GERD) treatment are symptom relief and
healing of oesophagitis. Besides proton pump inhibitors (PPIs), prokinetic agents are also …

Gastroesophageal reflux is defined as the passage of stomach contents into the esophagus
with or without accompanied regurgitation (spitting up) and vomiting. It is a normal …

Clinical use of gastric antisecretory drugs in pediatric patients with gastroesophageal reflux
disease: a narrative review - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Objective: The aim of this study was to evaluate the current implementation of the 2009
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition-European …

Introduction: Chronic idiopathic nausea (CIN) and functional dyspepsia (FD) cause
considerable strain on many children's lives and their families. Areas covered: This study …

Intestinal motility disorders represent a frequent problem in children with neurological
impairment. These conditions are characterized by abnormal movements of the gut, which …